Moderna Inc (MRNA) — Cash Flow-to-Debt Ratio
Moderna Inc (MRNA) has a Cash Flow-to-Debt Ratio of -0.15x as of March 2026, meaning its operating cash flow of $-630.00 Million could theoretically repay 0% of its total liabilities ($4.08 Billion) in one year. Explore Moderna Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Moderna Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Moderna Inc across 12 annual periods. Also explore MRNA total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Moderna Inc (2014–2025)
Year-by-year debt coverage analysis for Moderna Inc. For market capitalisation and broader financial context, see how much is Moderna Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.51x | $-1.87 Billion | $3.69 Billion | ▲ +45.2% |
| 2024 | -0.93x | $-3.00 Billion | $3.24 Billion | ▼ -35.9% |
| 2023 | -0.68x | $-3.12 Billion | $4.57 Billion | ▼ -192.2% |
| 2022 | 0.74x | $4.98 Billion | $6.74 Billion | ▼ -42.9% |
| 2021 | 1.29x | $13.62 Billion | $10.52 Billion | ▲ +204.9% |
| 2020 | 0.42x | $2.03 Billion | $4.78 Billion | ▲ +138.3% |
| 2019 | -1.11x | $-458.97 Million | $414.61 Million | ▼ -44.5% |
| 2018 | -0.77x | $-330.87 Million | $431.91 Million | ▼ -6.1% |
| 2017 | -0.72x | $-331.48 Million | $459.19 Million | ▼ -722.3% |
| 2016 | 0.12x | $66.73 Million | $575.31 Million | ▲ +102.7% |
| 2015 | -4.30x | $-738.15K | $171.66K | ▼ -1122.5% |
| 2014 | -0.35x | $-4.78 Million | $13.59 Million | — |